Early detection, increase cure rate and reduce mortality. The cure rate of early cancer is much higher than that of the middle and late stages, and the side effects of treatment are limited. The cure rate of early-detected cancer is over 90%, so it's particularly important to do early cancer detection.
Alercell is proud to introduce two new tests that are both first of their genre.

• LENA Q51R the first Leukemia Diagnostic Tests able to test up to 51 genes mutations.
• LENA S1R the first lung cancer diagnostic test based on methylation.